Table 2.
Case Reports of Alectinib-related Anemia.
Reference number | Age/ Gender |
Disesases | DAT | Erythrocyte morphological change | Decrease of Hpt |
---|---|---|---|---|---|
(3) | 85/M | NSCLC | Negative | (+) | (+) |
(4) | 62/M | NSCLC, α-thalassaemia | Negative | (+) | (+) |
(5) | 66/M | NSCLC, β-thalassaemia | Negative | (+) | (+) |
77/F | NSCLC | Negative | (+) | (-) | |
(6) | 79/F | NSCLC | No mention | (+) | No mention |
66/M | NSCLC | No mention | (+) | No mention | |
14/F | NSCLC | Negative | (+) | (-) | |
30/F | Neuroblastoma | No mention | (+) | (-) | |
66/M | NSCLC, β-thalassaemia | Negative | (+) | (+) | |
77/F | NSCLC | Negative | (+) | (+) |
DAT: direct antiglublin test, Hpt: haptoglobin, NSCLC: non-small cell lung carcinoma